TENET HEALTHCARE CORP (THC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 8B 16B 24B FY16: 21.1B FY17: 20.6B FY18: 18.3B FY19: 18.5B FY20: 17.6B FY21: 19.5B FY22: 19.2B FY23: 20.6B FY24: 20.7B FY25: 21.3B FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Gross Profit Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Annual

0 2.5B 5B 7.5B FY08: 311M FY09: 538M FY10: 634M FY11: 653M FY12: 749M FY13: 663M FY14: 925M FY15: 1.1B FY16: 1.2B FY17: 1.1B FY18: 1.6B FY19: 1.5B FY20: 2B FY21: 2.9B FY22: 2.3B FY23: 2.5B FY24: 6B FY25: 3.5B FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-1.5B 0 1.5B 3B 4.5B FY08: 25M FY09: 181M FY10: 1.1B FY11: 94M FY12: 133M FY13: -104M FY14: 76M FY15: 78M FY16: 176M FY17: -320M FY18: 459M FY19: 171M FY20: 768M FY21: 1.5B FY22: 1B FY23: 1.3B FY24: 4.1B FY25: 2.4B FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Annual

0 1.5B 3B 4.5B FY08: 208M FY09: 425M FY10: 472M FY11: 497M FY12: 593M FY13: 589M FY14: 687M FY15: 1B FY16: 558M FY17: 1.2B FY18: 1B FY19: 1.2B FY20: 3.4B FY21: 1.6B FY22: 1.1B FY23: 2.4B FY24: 2B FY25: 3.5B FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-1B 0 1B 2B 3B FY11: 30M FY12: 87M FY13: -102M FY14: -246M FY15: 184M FY16: -317M FY17: 493M FY18: 432M FY19: 563M FY20: 2.9B FY21: 910M FY22: 321M FY23: 1.6B FY24: 1.1B FY25: 2.5B FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 200M 400M 600M FY08: 478.6M FY09: 507.3M FY10: 140.2M FY11: 121.3M FY12: 108.9M FY13: 101.6M FY14: 100.3M FY15: 99.2M FY16: 99.3M FY17: 100.6M FY18: 103.9M FY19: 103.4M FY20: 106.3M FY21: 108.6M FY22: 110.5M FY23: 104.8M FY24: 97.9M FY25: 90.8M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-15.00 0.00 15.00 30.00 45.00 Q1 '10: 0.17 Q2 '10: 0.25 Q3 '10: 1.94 Q4 '10: 8.16 Q1 '11: 8.13 Q2 '11: 8.19 Q3 '11: 6.56 Q4 '11: 0.48 Q1 '12: 0.87 Q2 '13: -0.53 Q3 '13: -0.63 Q4 '13: -1.32 Q1 '14: -0.80 Q2 '15: 0.58 Q3 '15: 0.20 Q4 '15: -1.41 Q1 '16: -2.48 Q2 '16: -2.33 Q3 '17: -5.51 Q4 '17: -6.99 Q1 '18: -5.50 Q2 '20: -0.50 Q3 '20: -0.18 Q4 '20: 3.71 Q1 '21: 3.73 Q2 '21: 4.00 Q3 '21: 9.99 Q4 '21: 8.42 Q1 '22: 8.80 Q2 '23: 4.60 Q3 '23: 4.38 Q4 '23: 5.71 Q1 '24: 25.77 Q2 '24: 27.26 Q3 '24: 31.21 Q4 '24: 32.34 Q1 '25: 15.23 Q2 '25: 15.73 Q3 '25: 14.70 Q4 '25: 15.48 Q1 '26: 19.22 Q2 '26: 25.92 Q2 '11 Q4 '13 Q2 '16 Q4 '20 Q2 '23 Q4 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.